Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "nephrogenic diabetes insipidus"
Show Display Options
RSS Create an RSS feed from your search for:
"nephrogenic diabetes insipidus"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
2 Recruiting Metformin and Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: Metformin
3 Completed Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
Condition: Chronic Heart Failure
Intervention: Drug: Vasopressin V2 Receptor Antagonist
4 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
5 Not yet recruiting Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial
Condition: Bipolar Disorder
Interventions: Drug: Atorvastatin;   Other: placebo
6 Completed DILIPO (DILutIonal HyPOnatremia)
Condition: Congestive Heart Failure
Intervention: Drug: SR121463B

Study has passed its completion date and status has not been verified in more than two years.